PI
BMY icon

Parkside Investments’s Bristol-Myers Squibb BMY Stock Holding History

Parkside Investments’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-9,000
Closed -$509K – 93
2024
Q4 		$509K Sell
9,000
-9,000
-50% -$503K 0.08% 78
2024
Q3 		$931K Buy
+18,000
New +$844K 0.14% 64
2022
Q3 		– Sell
-66,188
Closed -$5.1M – 86
2022
Q2 		$5.1M Sell
66,188
-27,967
-30% -$2.13M 1.07% 39
2022
Q1 		$6.88M Sell
94,155
-30,894
-25% -$2.07M 1.35% 29
2021
Q4 		$7.8M Buy
125,049
+12,984
+12% +$762K 1.5% 21
2021
Q3 		$6.63M Sell
112,065
-1,521
-1% -$100K 1.39% 24
2021
Q2 		$7.59M Buy
113,586
+933
+0.8% +$60.8K 1.46% 20
2021
Q1 		$7.11M Buy
112,653
+22,633
+25% +$1.41M 1.48% 22
2020
Q4 		$5.58M Buy
90,020
+10,358
+13% +$637K 1.24% 31
2020
Q3 		$4.8M Sell
79,662
-442
-0.6% -$26.6K 1.26% 29
2020
Q2 		$4.71M Sell
80,104
-2,075
-3% -$124K 1.25% 24
2020
Q1 		$4.58M Sell
82,179
-16,125
-16% -$986K 1.51% 20
2019
Q4 		$6.31M Buy
98,304
+1,975
+2% +$113K 1.53% 17
2019
Q3 		$4.88M Buy
96,329
+7,250
+8% +$341K 1.31% 23
2019
Q2 		$7.46M Buy
89,079
+80,075
+889% +$3.73M 1.94% 10
2019
Q1 		$429K Buy
9,004
+4,000
+80% +$199K 0.12% 94
2018
Q4 		$260K Sell
5,004
-2,996
-37% -$161K 0.11% 102
2018
Q3 		$496K Buy
8,000
+2,600
+48% +$154K 0.23% 71
2018
Q2 		$299K Sell
5,400
-6,100
-53% -$329K 0.15% 82
2018
Q1 		$727K Buy
11,500
+8,500
+283% +$547K 0.38% 59
2017
Q4 		$184K Buy
+3,000
New +$188K 0.09% 96

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Parkside Investments's BMY Position: Q1 2025 in Review

Parkside Investments sold out of Bristol-Myers Squibb (BMY) in Q1 2025, closing a stake of 9,000 shares — an estimated $509K sold.

Parkside Investments first reported a position in BMY in Q4 2017 and held it in 21 quarters. The position peaked at $7.8M in Q4 2021. 2,476 funds tracked by Wall St. Rank hold BMY as of Q1 2025.

  • Parkside Investments reported no remaining Bristol-Myers Squibb position as of Q1 2025 after selling out during the quarter.
  • Parkside Investments sold 9,000 Bristol-Myers Squibb shares in Q1 2025, an estimated $509K.
  • Parkside Investments first reported a position in Bristol-Myers Squibb in Q4 2017 and held it in 21 quarters.
  • Parkside Investments's Bristol-Myers Squibb position peaked at $7.8M in Q4 2021.
  • 2,476 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2025.

Based on Parkside Investments's 13F filing for Q1 2025, filed 16 Apr 2025.